학술논문

Trypanosoma cruzi Secreted Cyclophilin Tc CyP19 as an Early Marker for Trypanocidal Treatment Efficiency.
Document Type
Article
Source
International Journal of Molecular Sciences. Aug2023, Vol. 24 Issue 15, p11875. 13p.
Subject
*TRYPANOSOMA cruzi
*CYCLOPHILINS
*CHAGAS' disease
*PROTEIN folding
Language
ISSN
1661-6596
Abstract
Cyclophilins (CyPs) are a family of enzymes involved in protein folding. Trypanosoma cruzi, the causative agent of Chagas disease, has a 19-kDa cyclophilin, TcCyP19, that was found to be secreted in parasite stages of the CL Brener clone and recognized by sera from T. cruzi-infected mice and patients. The levels of specific antibodies against TcCyP19 in T. cruzi-infected mice and subjects before and after drug treatment were measured by an in-house enzyme linked immunosorbent assay (ELISA). Mice in the acute and chronic phase of infection, with successful trypanocidal treatments, showed significantly lower anti-TcCyP19 antibody levels than untreated mice. In children and adults chronically infected with T. cruzi, a significant decrease in the anti-TcCyP19 titers was observed after 12 months of etiological treatment. This decrease was maintained in adult chronic patients followed-up 30–38 months post-treatment. These results encourage further studies on TcCyP19 as an early biomarker of trypanocidal treatment efficiency. [ABSTRACT FROM AUTHOR]